(Q36339566)

13 August 2017

1 reference

title

Anti-TGF-beta strategies for the treatment of chronic liver disease (English)

1 reference

13 August 2017

main subject

chronic liver disease

0 references

author name string

Katja Breitkopf

1

1 reference

13 August 2017

Stephan Haas

2

1 reference

13 August 2017

Eliza Wiercinska

3

1 reference

13 August 2017

Manfred V Singer

4

1 reference

13 August 2017

Steven Dooley

5

1 reference

13 August 2017

publication date

1 November 2005

1 reference

Alcoholism: Clinical and Experimental Research

13 August 2017

published in

1 reference

13 August 2017

volume

29

1 reference

13 August 2017

issue

11 Suppl

1 reference

13 August 2017

page(s)

121S-131S

1 reference

Activation by acetaldehyde of the promoter of the mouse alpha2(I) collagen gene when transfected into rat activated stellate cells

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000189284.98684.22

Natural inhibitor of transforming growth factor-β protects against scarring in experimental kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000189284.98684.22

Identification of novel inhibitors of the transforming growth factor beta1 (TGF-beta1) type 1 receptor (ALK5).

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000189284.98684.22

Acetaldehyde stimulates the activation of latent transforming growth factor-beta1 and induces expression of the type II receptor of the cytokine in rat cultured hepatic stellate cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000189284.98684.22

Hepatocyte growth factor and c-Met expression in rat and human liver fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000189284.98684.22

SB-505124 is a selective inhibitor of transforming growth factor-beta type I receptors ALK4, ALK5, and ALK7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000189284.98684.22

Pathogenesis of steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000189284.98684.22

Direct binding of Smad3 and Smad4 to critical TGF beta-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000189284.98684.22

Smad7 prevents activation of hepatic stellate cells and liver fibrosis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000189284.98684.22

Transforming growth factor-beta1 (TGF-beta)-induced apoptosis of prostate cancer cells involves Smad7-dependent activation of p38 by TGF-beta-activated kinase 1 and mitogen-activated protein kinase kinase 3

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000189284.98684.22

Smad3 as a mediator of the fibrotic response

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000189284.98684.22

Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000189284.98684.22

Lipid peroxidation, stellate cell activation and hepatic fibrogenesis in a rat model of chronic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000189284.98684.22

In vivo inhibition of rat stellate cell activation by soluble transforming growth factor beta type II receptor: a potential new therapy for hepatic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000189284.98684.22

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000189284.98684.22

Transforming growth factor-beta2 antibody attenuates fibrosis in the experimental diabetic rat kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000189284.98684.22

SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000189284.98684.22

Reverse transformation of hepatic myofibroblast-like cells by TGFbeta1/LAP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000189284.98684.22

A blocking peptide for transforming growth factor-β1 activation prevents hepatic fibrosis in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000189284.98684.22

Tubular epithelial-myofibroblast transdifferentiation mechanisms in proximal tubule cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000189284.98684.22

Activated natural killer T cells induce liver injury by Fas and tumor necrosis factor-alpha during alcohol consumption

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000189284.98684.22

Identification of Smad7, a TGFbeta-inducible antagonist of TGF-beta signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000189284.98684.22

Stimulation and proliferation of primary rat hepatic stellate cells by cytochrome P450 2E1-derived reactive oxygen species

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000189284.98684.22

Prevention of rat hepatic fibrosis by the protease inhibitor, camostat mesilate, via reduced generation of active TGF-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000189284.98684.22

Alcohol and hepatitis C virus core protein additively increase lipid peroxidation and synergistically trigger hepatic cytokine expression in a transgenic mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000189284.98684.22

Blockade of type beta transforming growth factor signaling prevents liver fibrosis and dysfunction in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000189284.98684.22

Blockade of TGF-beta by in vivo gene transfer of a soluble TGF-beta type II receptor in the muscle inhibits corneal opacification, edema and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000189284.98684.22

Mechanisms of TGF-beta-mediated apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000189284.98684.22

Mechanisms of TGF-beta signaling from cell membrane to the nucleus

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000189284.98684.22

Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000189284.98684.22

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000189284.98684.22

New insights into TGF-beta-Smad signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000189284.98684.22

Conditional tetracycline-regulated expression of TGF-β1 in liver of transgenic mice leads to reversible intermediary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000189284.98684.22

Hepatocyte growth factor gene therapy of liver cirrhosis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000189284.98684.22

TGF-beta signaling: positive and negative effects on tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000189284.98684.22

TGF-beta receptor kinase inhibitor enhances growth and integrity of embryonic stem cell-derived endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000189284.98684.22

Combining TGF-beta inhibition and angiotensin II blockade results in enhanced antifibrotic effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000189284.98684.22

BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000189284.98684.22

Physiological consequences of loss of plasminogen activator gene function in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000189284.98684.22

10.1097/01.ALC.0000189284.98684.22

21 January 2018

Identifiers

DOI

1 reference

13 August 2017

1 reference